Long-term outcomes of subjects with Epstein-Barr virus-driven post-transplant lymphoproliferative disorder (EBV+PTLD) following solid organ (SOT) or allogeneic hematopoietic cell transplants (HCT) treated with tabelecleucel on an expanded access program Meeting Abstract
| Authors: | Prockop, S.; Reshef, R.; Tsai, D. E.; Bunin, N.; Abu-Arja, R.; Mahadeo, K. M.; Weng, W. K.; Van Besien, K.; Loeb, D.; Nasta, S. D.; Nemecek, E. R.; Hiremath, M.; Yue, S.; Sun, Y.; Navarro, W.; Nikiforow, S. |
| Abstract Title: | Long-term outcomes of subjects with Epstein-Barr virus-driven post-transplant lymphoproliferative disorder (EBV+PTLD) following solid organ (SOT) or allogeneic hematopoietic cell transplants (HCT) treated with tabelecleucel on an expanded access program |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577164602094 |
| DOI: | 10.1182/blood-2019-124904 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4071 -- Source: Wos |
